|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics. CA Cancer J Clin. 60:277–300. 2010.
|
|
3
|
Aggarwal BB and Shishodia S: Molecular
targets of dietary agents for prevention and therapy of cancer.
Biochem Pharmacol. 71:1397–1421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Velicer CM and Ulrich CM: Vitamin and
mineral supplement use among US adults after cancer diagnosis: a
systematic review. J Clin Oncol. 26:665–673. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miller MF, Bellizzi KM, Sufian M, Ambs AH,
Goldstein MS and Ballard-Barbash R: Dietary supplement use in
individuals living with cancer and other chronic conditions: a
population-based study. J Am Diet Assoc. 108:483–494. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang J, Wojnowski R, Jedinak A and Sliva
D: Suppression of proliferation and invasive behavior of human
metastatic breast cancer cells by dietary supplement BreastDefend.
Integr Cancer Ther. 10:192–200. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ho CY, Kim CF, Leung KN, Fung KP, Tse TF,
Chan H and Lau CB: Differential anti-tumor activity of Coriolus
versicolor (Yunzhi) extract through p53- and/or Bcl-2-dependent
apoptotic pathway in human breast cancer cells. Cancer Biol Ther.
4:638–644. 2005.PubMed/NCBI
|
|
8
|
Jiang J, Slivova V and Sliva D:
Ganoderma lucidum inhibits proliferation of human breast
cancer cells by downregulation of estrogen receptor and NF-kappaB
signaling. Int J Oncol. 29:695–703. 2006.
|
|
9
|
Thyagarajan A, Jiang J, Hopf A, Adamec J
and Sliva D: Inhibition of oxidative stress-induced invasiveness of
cancer cells by Ganoderma lucidum is mediated through the
suppression of interleukin-8 secretion. Int J Mol Med. 18:657–664.
2006.PubMed/NCBI
|
|
10
|
Sliva D: Suppression of cancer
invasiveness by dietary compounds. Mini Rev Med Chem. 8:677–688.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bui-Xuan NH, Tang PM, Wong CK and Fung KP:
Photo-activated pheophorbide-a, an active component of Scutellaria
barbata, enhances apoptosis via the suppression of ERK-mediated
autophagy in the estrogen receptor-negative human breast
adenocarcinoma cells MDA-MB-231. J Ethnopharmacol. 131:95–103.
2010. View Article : Google Scholar
|
|
12
|
Ye MN and Chen HF: Effects of Astragalus
injection on proliferation of basal-like breast cancer cell line
MDA-MB-468. Zhong Xi Yi Jie He Xue Bao. 6:399–404. 2008.PubMed/NCBI
|
|
13
|
Shao ZM, Shen ZZ, Liu CH, Sartippour MR,
Go VL, Heber D and Nguyen M: Curcumin exerts multiple suppressive
effects on human breast carcinoma cells. Int J Cancer. 98:234–240.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bachmeier B, Nerlich AG, Iancu CM, Cilli
M, Schleicher E, Vené R, Dell’Eva R, et al: The chemopreventive
polyphenol Curcumin prevents hematogenous breast cancer metastases
in immunodeficient mice. Cell Physiol Biochem. 19:137–152. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schlachterman A, Valle F, Wall KM, Azios
NG, Castillo L, Morell L, Washington AV, et al: Combined
resveratrol, quercetin, and catechin treatment reduces breast tumor
growth in a nude mouse model. Transl Oncol. 1:19–27. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Castillo-Pichardo L, Martínez-Montemayor
MM, Martínez JE, Wall KM, Cubano LA and Dharmawardhane S:
Inhibition of mammary tumor growth and metastases to bone and liver
by dietary grape polyphenols. Clin Exp Metastasis. 26:505–516.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hsu EL, Chen N, Westbrook A, Wang F, Zhang
R, Taylor RT and Hankinson O: CXCR4 and CXCL12 down-regulation: a
novel mechanism for the chemoprotection of 3,3′-diindolylmethane
for breast and ovarian cancers. Cancer Lett. 265:113–123.
2008.PubMed/NCBI
|
|
18
|
Ahmad A, Kong D, Wang Z, Sarkar SH,
Banerjee S and Sarkar FH: Down-regulation of uPA and uPAR by
3,3′-diindolylmethane contributes to the inhibition of cell growth
and migration of breast cancer cells. J Cell Biochem. 108:916–925.
2009.
|
|
19
|
Elliott BE, Meens JA, SenGupta SK, Louvard
D and Arpin M: The membrane cytoskeletal crosslinker ezrin is
required for metastasis of breast carcinoma cells. Breast Cancer
Res. 7:R365–R373. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gelmann EP, Thompson EW and Sommers CL:
Invasive and metastatic properties of MCF-7 cells and
rasH-transfected MCF-7 cell lines. Int J Cancer. 50:665–669. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xue C, Plieth D, Venkov C, Xu C and
Neilson EG: The gatekeeper effect of epithelial-mesenchymal
transition regulates the frequency of breast cancer metastasis.
Cancer Res. 63:3386–3394. 2003.PubMed/NCBI
|
|
22
|
Vanzulli SI, Soldati R, Meiss R, Colombo
L, Molinolo AA and Lanari C: Estrogen or antiprogestin treatment
induces complete regression of pulmonary and axillary metastases in
an experimental model of breast cancer progression. Carcinogenesis.
26:1055–1063. 2005. View Article : Google Scholar
|
|
23
|
Zhao J, Ni H, Ma Y, Dong L, Dai J, Zhao F,
Yan X, et al: TIP30/CC3 expression in breast carcinoma: relation to
metastasis, clinicopathologic parameters, and P53 expression. Hum
Pathol. 38:293–298. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aggarwal BB, Shishodia S, Takada Y,
Banerjee S, Newman RA, Bueso-Ramos CE and Price JE: Curcumin
suppresses the paclitaxel-induced nuclear factor-kappaB pathway in
breast cancer cells and inhibits lung metastasis of human breast
cancer in nude mice. Clin Cancer Res. 11:7490–7498. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee WJ, Chen WK, Wang CJ, Lin WL and Tseng
TH: Apigenin inhibits HGF-promoted invasive growth and metastasis
involving blocking PI3K/Akt pathway and beta 4 integrin function in
MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol.
226:178–191. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ishihara Y, Iijima H and Matsunaga K:
Contribution of cytokines on the suppression of lung metastasis.
Biotherapy. 11:267–275. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maehara Y, Tsujitani S, Saeki H, Oki E,
Yoshinaga K, Emi Y, Morita M, et al: Biological mechanism and
clinical effect of protein-bound polysaccharide K
(KRESTIN(®)): review of development and future
perspectives. Surg Today. 42:8–28. 2012. View Article : Google Scholar
|
|
28
|
Han SB, Lee CW, Jeon YJ, Hong ND, Yoo ID,
Yang KH and Kim HM: The inhibitory effect of polysaccharides
isolated from Phellinus linteus on tumor growth and metastasis.
Immunopharmacology. 41:157–164. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee HJ, Lee HJ, Lim ES, Ahn KS, Shim BS,
Kim HM, Gong SJ, et al: Cambodian Phellinus linteus inhibits
experimental metastasis of melanoma cells in mice via regulation of
urokinase type plasminogen activator. Biol Pharm Bull. 28:27–31.
2005.PubMed/NCBI
|
|
30
|
Kimura Y, Taniguchi M and Baba K:
Antitumor and antimetastatic effects on liver of triterpenoid
fractions of Ganoderma lucidum: mechanism of action and
isolation of an active substance. Anticancer Res. 22:3309–3318.
2002.PubMed/NCBI
|
|
31
|
Nonaka Y, Ishibashi H, Nakai M, Shibata H,
Kiso Y and Abe S: Effects of the antlered form of Ganoderma
lucidum on tumor growth and metastasis in
cyclophosphamide-treated mice. Biosci Biotechnol Biochem.
72:1399–1408. 2008.PubMed/NCBI
|
|
32
|
Chen NH, Liu JW and Zhong JJ: Ganoderic
acid T inhibits tumor invasion in vitro and in vivo through
inhibition of MMP expression. Pharmacol Rep. 62:150–163. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim EJ, Shin M, Park H, Hong JE, Shin HK,
Kim J, Kwon DY, et al: Oral administration of 3,3′-diindolylmethane
inhibits lung metastasis of 4T1 murine mammary carcinoma cells in
BALB/c mice. J Nutr. 139:2373–2379. 2009.
|
|
34
|
Sliva D, Jedinak A, Kawasaki J, Harvey K
and Slivova V: Phellinus linteus suppresses growth,
angiogenesis and invasive behaviour of breast cancer cells through
the inhibition of AKT signalling. Br J Cancer. 98:1348–1356. 2008.
View Article : Google Scholar
|
|
35
|
Han B, Nakamura M, Mori I, Nakamura Y and
Kakudo K: Urokinase-type plasminogen activator system and breast
cancer (review). Oncol Rep. 14:105–112. 2005.PubMed/NCBI
|
|
36
|
Frandsen TL, Holst-Hansen C, Nielsen BS,
Christensen IJ, Nyengaard JR, Carmeliet P and Brünner N: Direct
evidence of the importance of stromal urokinase plasminogen
activator (uPA) in the growth of an experimental human breast
cancer using a combined uPA gene-disrupted and immunodeficient
xenograft model. Cancer Res. 61:532–537. 2001.
|
|
37
|
Müller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, et al: Involvement of chemokine
receptors in breast cancer metastasis. Nature. 410:50–56.
2001.PubMed/NCBI
|
|
38
|
Liang Z, Yoon Y, Votaw J, Goodman MM,
Williams L and Shim H: Silencing of CXCR4 blocks breast cancer
metastasis. Cancer Res. 65:967–671. 2005.PubMed/NCBI
|
|
39
|
Ma WF, Du J, Fu LP, Fang R, Chen HY and
Cai SH: Phenotypic knockout of CXCR4 by a novel recombinant protein
TAT/54R/KDEL inhibits tumors metastasis. Mol Cancer Res.
7:1613–1621. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim J, Thorne SH, Sun L, Huang B and
Mochly-Rosen D: Sustained inhibition of PKCα reduces intravasation
and lung seeding during mammary tumor metastasis in an in vivo
mouse model. Oncogene. 30:323–333. 2011.
|
|
41
|
Giricz O, Calvo V, Pero SC, Krag DN,
Sparano JA and Kenny PA: GRB7 is required for triple-negative
breast cancer cell invasion and survival. Breast Cancer Res Treat.
Oct 18–2011.(Epub ahead of print).
|
|
42
|
Cleator S, Heller W and Coombes RC:
Triple-negative breast cancer: therapeutic options. Lancet Oncol.
8:235–244. 2007. View Article : Google Scholar : PubMed/NCBI
|
